# Moderna’s candidate COVID-19 vaccine looks to protect 94.5% of those who get it, trial shows

- Link: https://www.widthness.com/modernas-candidate-covid-19-vaccine-looks-to-protect-94-5-of-those-who-get-it-trial-shows/
- Published: 2020-11-17T09:30:38-06:00
- Author: Curated by Theresa Wysocki

Article by Karen Weintraub, USA TODAY. A second COVID-19 candidate vaccine looks to be even more effective than the first: Both protect more than 90%  of those who get the shots. Moderna, a Cambridge, Massachusetts-based biotechnology company, announced early Monday that its candidate vaccine, mRNA-1273, developed in collaboration with the U.S. government, appears to be 94.5% effective against the disease. […] Click here to view original web page at www.usatoday.com